Skip to main content
Clinical Trials/JPRN-jRCT1030220176
JPRN-jRCT1030220176
Not yet recruiting
未知

Evaluation of long-term rehabilitation and nutritional management for tailored medicine after esophageal cancer surgery

SATO HIROSHI0 sites60 target enrollmentJuly 2, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Esophageal Cancer
Sponsor
SATO HIROSHI
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 2, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
SATO HIROSHI

Eligibility Criteria

Inclusion Criteria

  • 1\) The primary lesion is located in the cervical, thoracic esophagus, or esophagogastric junction (UICC\-TNM, 8th edition).
  • 2\) Histopathologically diagnosed as squamous cell carcinoma, adenosquamous cell carcinoma, or basal cell carcinoma.
  • 3\) The patient is scheduled to receive preoperative adjuvant therapy (chemotherapy, chemoradiotherapy) and radical open surgery (including specular surgery).
  • 4\) Written consent has been obtained from the patient.
  • 5\) Patient is 20 years of age or older and under 80 years of age.
  • 6\) Patient has a PS of 0 or 1\.
  • 7\) Patients do not have active multiple cancers.
  • 8\) Patient has preserved organ function.

Exclusion Criteria

  • 1\) Inability to give consent to participate in the study
  • 2\) Difficulty in making regular visits to the hospital

Outcomes

Primary Outcomes

Not specified

Similar Trials